Most Recent
Construction PRO
Liquidators of collapsed Snowdon Developments have reached a settlement with cement supplier Barro Group as part of efforts to claw back payments allegedly made when the Melbourne developer was insolvent.
Ashurst has appointed a new partner to its restructuring and governance practice, nabbing a partner from HWL Ebsworth who represented the receivers of investment platform Brite Advisors.
Ex-Keystone director Paul Chiodo has failed in his fight against subpoenas by receivers over bank statements, despite arguing they were a fishing expedition aimed at clawing back investor funds.
A landmark class action over alleged systematic sexual violence, discrimination and harassment in the Australian Defence Force will argue that the Sex Discrimination Act applies to incidents that occurred overseas.
Construction PRO
An appeals court has affirmed a decision which found the Western Australian government's decision to expedite an exploration application by mining company Uro Western is not subject to judicial review.
Coles changed its marketing policies after being concerned it could not compete with Woolworths, a court has heard on the first day of trial in the consumer regulator’s case over the supermarket's “utterly misleading” discounts.
CBA plans to file a cross-appeal in the class actions before the High Court, contending the shareholders -- who argue they should have won their loss case -- failed to establish disclosure breaches at the threshold.
Construction PRO
Qube's board has accepted an $11.7 billion takeover offer by a Macquarie Asset Management-led consortium, saying the deal represents a "significant premium" on the infrastructure giant's share price.
The start-up behind Hungry Jack's plant-based 'Rebel Whopper' wants a court to review IP Australia's decision that a proposed patent covering its fake meat product didn't pass muster.
Private hospital operator Ramsay Health has won swift ACCC approval for its $251 million acquisition of Canberra hospital National Capital Private Hospital from Healthscope, with the regulator completing its review in three weeks.